Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

DEF 14A

SEC Filing Details

Document Details

Filing Date
Jun 26, 2019
Document Date
Aug 8, 2019
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.